Hess G, Dreyling M, Oberic L, Gine E, et al. Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma. Leuk Lymphoma 2023 Oct 16:1-12. doi: 10.1080/10428194.2023.2268228.
PMID: 37840282